Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Precision Cancer Therapies Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Hormone Therapy
1.2.3 Immunotherapies
1.2.4 Targeted Therapy
1.2.5 Monoclonal Antibody Therapy
1.2.6 Gene Therapy
1.3 Market by Application
1.3.1 Global Precision Cancer Therapies Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Diagnostic Centers
1.3.4 Oncology Clinics
1.3.5 Research Institutes
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Precision Cancer Therapies Market Perspective (2018-2033)
2.2 Precision Cancer Therapies Growth Trends by Region
2.2.1 Global Precision Cancer Therapies Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Precision Cancer Therapies Historic Market Size by Region (2018-2023)
2.2.3 Precision Cancer Therapies Forecasted Market Size by Region (2024-2033)
2.3 Precision Cancer Therapies Market Dynamics
2.3.1 Precision Cancer Therapies Industry Trends
2.3.2 Precision Cancer Therapies Market Drivers
2.3.3 Precision Cancer Therapies Market Challenges
2.3.4 Precision Cancer Therapies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Precision Cancer Therapies Players by Revenue
3.1.1 Global Top Precision Cancer Therapies Players by Revenue (2018-2023)
3.1.2 Global Precision Cancer Therapies Revenue Market Share by Players (2018-2023)
3.2 Global Precision Cancer Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Precision Cancer Therapies Revenue
3.4 Global Precision Cancer Therapies Market Concentration Ratio
3.4.1 Global Precision Cancer Therapies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Precision Cancer Therapies Revenue in 2022
3.5 Precision Cancer Therapies Key Players Head office and Area Served
3.6 Key Players Precision Cancer Therapies Product Solution and Service
3.7 Date of Enter into Precision Cancer Therapies Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Precision Cancer Therapies Breakdown Data by Type
4.1 Global Precision Cancer Therapies Historic Market Size by Type (2018-2023)
4.2 Global Precision Cancer Therapies Forecasted Market Size by Type (2024-2033)
5 Precision Cancer Therapies Breakdown Data by Application
5.1 Global Precision Cancer Therapies Historic Market Size by Application (2018-2023)
5.2 Global Precision Cancer Therapies Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Precision Cancer Therapies Market Size (2018-2033)
6.2 North America Precision Cancer Therapies Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Precision Cancer Therapies Market Size by Country (2018-2023)
6.4 North America Precision Cancer Therapies Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Precision Cancer Therapies Market Size (2018-2033)
7.2 Europe Precision Cancer Therapies Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Precision Cancer Therapies Market Size by Country (2018-2023)
7.4 Europe Precision Cancer Therapies Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Precision Cancer Therapies Market Size (2018-2033)
8.2 Asia-Pacific Precision Cancer Therapies Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Precision Cancer Therapies Market Size by Region (2018-2023)
8.4 Asia-Pacific Precision Cancer Therapies Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Precision Cancer Therapies Market Size (2018-2033)
9.2 Latin America Precision Cancer Therapies Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Precision Cancer Therapies Market Size by Country (2018-2023)
9.4 Latin America Precision Cancer Therapies Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Precision Cancer Therapies Market Size (2018-2033)
10.2 Middle East & Africa Precision Cancer Therapies Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Precision Cancer Therapies Market Size by Country (2018-2023)
10.4 Middle East & Africa Precision Cancer Therapies Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Precision Cancer Therapies Introduction
11.1.4 Abbott Laboratories Revenue in Precision Cancer Therapies Business (2018-2023)
11.1.5 Abbott Laboratories Recent Development
11.2 Bayer HealthCare
11.2.1 Bayer HealthCare Company Detail
11.2.2 Bayer HealthCare Business Overview
11.2.3 Bayer HealthCare Precision Cancer Therapies Introduction
11.2.4 Bayer HealthCare Revenue in Precision Cancer Therapies Business (2018-2023)
11.2.5 Bayer HealthCare Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Detail
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Precision Cancer Therapies Introduction
11.3.4 GlaxoSmithKline Revenue in Precision Cancer Therapies Business (2018-2023)
11.3.5 GlaxoSmithKline Recent Development
11.4 OncoGenex Pharmaceuticals
11.4.1 OncoGenex Pharmaceuticals Company Detail
11.4.2 OncoGenex Pharmaceuticals Business Overview
11.4.3 OncoGenex Pharmaceuticals Precision Cancer Therapies Introduction
11.4.4 OncoGenex Pharmaceuticals Revenue in Precision Cancer Therapies Business (2018-2023)
11.4.5 OncoGenex Pharmaceuticals Recent Development
11.5 Hospira
11.5.1 Hospira Company Detail
11.5.2 Hospira Business Overview
11.5.3 Hospira Precision Cancer Therapies Introduction
11.5.4 Hospira Revenue in Precision Cancer Therapies Business (2018-2023)
11.5.5 Hospira Recent Development
11.6 Boehringer Ingelheim
11.6.1 Boehringer Ingelheim Company Detail
11.6.2 Boehringer Ingelheim Business Overview
11.6.3 Boehringer Ingelheim Precision Cancer Therapies Introduction
11.6.4 Boehringer Ingelheim Revenue in Precision Cancer Therapies Business (2018-2023)
11.6.5 Boehringer Ingelheim Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Detail
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Precision Cancer Therapies Introduction
11.7.4 AstraZeneca Revenue in Precision Cancer Therapies Business (2018-2023)
11.7.5 AstraZeneca Recent Development
11.8 Aveo Pharmaceuticals
11.8.1 Aveo Pharmaceuticals Company Detail
11.8.2 Aveo Pharmaceuticals Business Overview
11.8.3 Aveo Pharmaceuticals Precision Cancer Therapies Introduction
11.8.4 Aveo Pharmaceuticals Revenue in Precision Cancer Therapies Business (2018-2023)
11.8.5 Aveo Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Precision Cancer Therapies Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Hormone Therapy
Table 3. Key Players of Immunotherapies
Table 4. Key Players of Targeted Therapy
Table 5. Key Players of Monoclonal Antibody Therapy
Table 6. Key Players of Gene Therapy
Table 7. Global Precision Cancer Therapies Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Precision Cancer Therapies Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Precision Cancer Therapies Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Precision Cancer Therapies Market Share by Region (2018-2023)
Table 11. Global Precision Cancer Therapies Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 12. Global Precision Cancer Therapies Market Share by Region (2024-2033)
Table 13. Precision Cancer Therapies Market Trends
Table 14. Precision Cancer Therapies Market Drivers
Table 15. Precision Cancer Therapies Market Challenges
Table 16. Precision Cancer Therapies Market Restraints
Table 17. Global Precision Cancer Therapies Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Precision Cancer Therapies Market Share by Players (2018-2023)
Table 19. Global Top Precision Cancer Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Precision Cancer Therapies as of 2022)
Table 20. Ranking of Global Top Precision Cancer Therapies Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Precision Cancer Therapies Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Precision Cancer Therapies Product Solution and Service
Table 24. Date of Enter into Precision Cancer Therapies Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Precision Cancer Therapies Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Precision Cancer Therapies Revenue Market Share by Type (2018-2023)
Table 28. Global Precision Cancer Therapies Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 29. Global Precision Cancer Therapies Revenue Market Share by Type (2024-2033)
Table 30. Global Precision Cancer Therapies Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Precision Cancer Therapies Revenue Market Share by Application (2018-2023)
Table 32. Global Precision Cancer Therapies Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 33. Global Precision Cancer Therapies Revenue Market Share by Application (2024-2033)
Table 34. North America Precision Cancer Therapies Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. North America Precision Cancer Therapies Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Precision Cancer Therapies Market Size by Country (2024-2033) & (US$ Million)
Table 37. Europe Precision Cancer Therapies Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. Europe Precision Cancer Therapies Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Precision Cancer Therapies Market Size by Country (2024-2033) & (US$ Million)
Table 40. Asia-Pacific Precision Cancer Therapies Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 41. Asia-Pacific Precision Cancer Therapies Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Precision Cancer Therapies Market Size by Region (2024-2033) & (US$ Million)
Table 43. Latin America Precision Cancer Therapies Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Latin America Precision Cancer Therapies Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Precision Cancer Therapies Market Size by Country (2024-2033) & (US$ Million)
Table 46. Middle East & Africa Precision Cancer Therapies Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 47. Middle East & Africa Precision Cancer Therapies Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Precision Cancer Therapies Market Size by Country (2024-2033) & (US$ Million)
Table 49. Abbott Laboratories Company Detail
Table 50. Abbott Laboratories Business Overview
Table 51. Abbott Laboratories Precision Cancer Therapies Product
Table 52. Abbott Laboratories Revenue in Precision Cancer Therapies Business (2018-2023) & (US$ Million)
Table 53. Abbott Laboratories Recent Development
Table 54. Bayer HealthCare Company Detail
Table 55. Bayer HealthCare Business Overview
Table 56. Bayer HealthCare Precision Cancer Therapies Product
Table 57. Bayer HealthCare Revenue in Precision Cancer Therapies Business (2018-2023) & (US$ Million)
Table 58. Bayer HealthCare Recent Development
Table 59. GlaxoSmithKline Company Detail
Table 60. GlaxoSmithKline Business Overview
Table 61. GlaxoSmithKline Precision Cancer Therapies Product
Table 62. GlaxoSmithKline Revenue in Precision Cancer Therapies Business (2018-2023) & (US$ Million)
Table 63. GlaxoSmithKline Recent Development
Table 64. OncoGenex Pharmaceuticals Company Detail
Table 65. OncoGenex Pharmaceuticals Business Overview
Table 66. OncoGenex Pharmaceuticals Precision Cancer Therapies Product
Table 67. OncoGenex Pharmaceuticals Revenue in Precision Cancer Therapies Business (2018-2023) & (US$ Million)
Table 68. OncoGenex Pharmaceuticals Recent Development
Table 69. Hospira Company Detail
Table 70. Hospira Business Overview
Table 71. Hospira Precision Cancer Therapies Product
Table 72. Hospira Revenue in Precision Cancer Therapies Business (2018-2023) & (US$ Million)
Table 73. Hospira Recent Development
Table 74. Boehringer Ingelheim Company Detail
Table 75. Boehringer Ingelheim Business Overview
Table 76. Boehringer Ingelheim Precision Cancer Therapies Product
Table 77. Boehringer Ingelheim Revenue in Precision Cancer Therapies Business (2018-2023) & (US$ Million)
Table 78. Boehringer Ingelheim Recent Development
Table 79. AstraZeneca Company Detail
Table 80. AstraZeneca Business Overview
Table 81. AstraZeneca Precision Cancer Therapies Product
Table 82. AstraZeneca Revenue in Precision Cancer Therapies Business (2018-2023) & (US$ Million)
Table 83. AstraZeneca Recent Development
Table 84. Aveo Pharmaceuticals Company Detail
Table 85. Aveo Pharmaceuticals Business Overview
Table 86. Aveo Pharmaceuticals Precision Cancer Therapies Product
Table 87. Aveo Pharmaceuticals Revenue in Precision Cancer Therapies Business (2018-2023) & (US$ Million)
Table 88. Aveo Pharmaceuticals Recent Development
Table 89. Research Programs/Design for This Report
Table 90. Key Data Information from Secondary Sources
Table 91. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Precision Cancer Therapies Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Precision Cancer Therapies Market Share by Type: 2022 VS 2033
Figure 3. Hormone Therapy Features
Figure 4. Immunotherapies Features
Figure 5. Targeted Therapy Features
Figure 6. Monoclonal Antibody Therapy Features
Figure 7. Gene Therapy Features
Figure 8. Global Precision Cancer Therapies Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 9. Global Precision Cancer Therapies Market Share by Application: 2022 VS 2033
Figure 10. Hospitals Case Studies
Figure 11. Diagnostic Centers Case Studies
Figure 12. Oncology Clinics Case Studies
Figure 13. Research Institutes Case Studies
Figure 14. Precision Cancer Therapies Report Years Considered
Figure 15. Global Precision Cancer Therapies Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 16. Global Precision Cancer Therapies Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 17. Global Precision Cancer Therapies Market Share by Region: 2022 VS 2033
Figure 18. Global Precision Cancer Therapies Market Share by Players in 2022
Figure 19. Global Top Precision Cancer Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Precision Cancer Therapies as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Precision Cancer Therapies Revenue in 2022
Figure 21. North America Precision Cancer Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. North America Precision Cancer Therapies Market Share by Country (2018-2033)
Figure 23. United States Precision Cancer Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Canada Precision Cancer Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Precision Cancer Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Europe Precision Cancer Therapies Market Share by Country (2018-2033)
Figure 27. Germany Precision Cancer Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. France Precision Cancer Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. U.K. Precision Cancer Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Italy Precision Cancer Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Russia Precision Cancer Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Nordic Countries Precision Cancer Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific Precision Cancer Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Asia-Pacific Precision Cancer Therapies Market Share by Region (2018-2033)
Figure 35. China Precision Cancer Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Japan Precision Cancer Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. South Korea Precision Cancer Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Southeast Asia Precision Cancer Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. India Precision Cancer Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Australia Precision Cancer Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America Precision Cancer Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Latin America Precision Cancer Therapies Market Share by Country (2018-2033)
Figure 43. Mexico Precision Cancer Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Brazil Precision Cancer Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa Precision Cancer Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East & Africa Precision Cancer Therapies Market Share by Country (2018-2033)
Figure 47. Turkey Precision Cancer Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Saudi Arabia Precision Cancer Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Abbott Laboratories Revenue Growth Rate in Precision Cancer Therapies Business (2018-2023)
Figure 50. Bayer HealthCare Revenue Growth Rate in Precision Cancer Therapies Business (2018-2023)
Figure 51. GlaxoSmithKline Revenue Growth Rate in Precision Cancer Therapies Business (2018-2023)
Figure 52. OncoGenex Pharmaceuticals Revenue Growth Rate in Precision Cancer Therapies Business (2018-2023)
Figure 53. Hospira Revenue Growth Rate in Precision Cancer Therapies Business (2018-2023)
Figure 54. Boehringer Ingelheim Revenue Growth Rate in Precision Cancer Therapies Business (2018-2023)
Figure 55. AstraZeneca Revenue Growth Rate in Precision Cancer Therapies Business (2018-2023)
Figure 56. Aveo Pharmaceuticals Revenue Growth Rate in Precision Cancer Therapies Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed